Education
About Us
Working with TipRanks
Follow Us
Sequent Scientific Limited (IN:SEQUENT)
:SEQUENT
SEQUENT Stock Chart & Stats
₹209.25
-₹3.94(-2.00%)
At close: 4:00 PM EST
₹209.25
-₹3.94(-2.00%)
Day’s Range― - ―
52-Week Range₹111.00 - ₹260.30
Previous CloseN/A
Volume390.67K
Average Volume (3M)119.95K
Market Cap
₹53.31B
Enterprise Value₹52.38B
Total Cash (Recent Filing)₹630.78M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)126.6
Beta1.51
Next Earnings
Feb 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.59
Shares Outstanding252,949,340
10 Day Avg. Volume209,903
30 Day Avg. Volume119,946
Financial Highlights & Ratios
PEG Ratio-0.99
Price to Book (P/B)4.96
Price to Sales (P/S)2.25
P/FCF Ratio78.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)677.97
Revenue Forecast (FY)₹1.47T
Sequent Scientific Limited News
SEQUENT FAQ
What was Sequent Scientific Limited’s price range in the past 12 months?
Sequent Scientific Limited lowest stock price was ₹111.00 and its highest was ₹260.30 in the past 12 months.
What is Sequent Scientific Limited’s market cap?
Sequent Scientific Limited’s market cap is ₹53.31B.
When is Sequent Scientific Limited’s upcoming earnings report date?
Sequent Scientific Limited’s upcoming earnings report date is Feb 17, 2026 which is in 60 days.
How were Sequent Scientific Limited’s earnings last quarter?
Sequent Scientific Limited released its earnings results on Nov 14, 2025. The company reported ₹0.587 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.587.
Is Sequent Scientific Limited overvalued?
According to Wall Street analysts Sequent Scientific Limited’s price is currently Overvalued.
Does Sequent Scientific Limited pay dividends?
Sequent Scientific Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Sequent Scientific Limited dividends here
What is Sequent Scientific Limited’s EPS estimate?
Sequent Scientific Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sequent Scientific Limited have?
Sequent Scientific Limited has 252,949,340 shares outstanding.
What happened to Sequent Scientific Limited’s price movement after its last earnings report?
Sequent Scientific Limited reported an EPS of ₹0.587 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.109%.
Which hedge fund is a major shareholder of Sequent Scientific Limited?
Currently, no hedge funds are holding shares in IN:SEQUENT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sequent Scientific Limited
Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.
Technical Analysis
Aarti Drugs Limited
―
Advanced Enzyme Technologies Ltd
―
Glenmark Pharmaceuticals Limited
―
Sun Pharma Advanced Research Co. Ltd.
―
Suven Life Sciences Limited
―